Oxidative stress and regional ischemia-reperfusion injury: the peroxynitrite–poly(ADP-ribose) polymerase connection

This publication has 39 references indexed in Scilit:

• The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors
  Pharmacological Reviews, 2002
• BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase
  Biochemical Pharmacology, 2000
• Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate–nitric oxide neurotransmission
  Proceedings of the National Academy of Sciences, 2000
• Molecular mechanism of the short-term cardiotoxicity caused by 2′,3′-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions
  Biochemical Pharmacology, 1999
• An inhibitor of poly (ADP‐ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart
  British Journal of Pharmacology, 1999
• Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat
  Free Radical Biology & Medicine, 1999
• Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress
  Cardiovascular Research, 1999
• Role of poly(ADP-ribose) synthetase in inflammation and ischaemia–reperfusion
  Trends in Pharmacological Sciences, 1998
• Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase
  Cardiovascular Research, 1997
• Protection by Inhibition of Poly (ADP-ribose) Synthetase Against Oxidant Injury in Cardiac MyoblastsIn Vitro
  Journal of Molecular and Cellular Cardiology, 1997